To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma
Clinical trial NCT02260804 · COMPLETED
Trial details
- NCT number
- NCT02260804
- Sponsor
- Celltrion
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-09
- Primary completion
- 2018-01-04
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.